Clinical trial

How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose

NCT00574041

Study summary

ClinicalTrials.gov

How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Interferon beta-1a Normalized identity: interferon beta-1a View linked drug · Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2007-06-01

PhasePHASE4

Conditions

Relapsing Remitting Multiple Sclerosisunresolved

Interventions

Interferon beta-1aDRUG · verified · RxNorm: interferon beta-1a

Sponsors & collaborators

Biogenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00574041 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.